Os Therapies Incorporated
(OSTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2002 | 12-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,883 | -7,792 | -6,255 | -4,400 | -3,090 |
| Depreciation Amortization | 1,429 | 2,651 | 1,152 | 710 | 720 |
| Accounts payable and accrued liabilities | -1,053 | 1,348 | 216 | N/A | N/A |
| Other Working Capital | -130 | 2,017 | 947 | 390 | -630 |
| Other Operating Activity | 1,355 | -1,231 | 146 | 650 | 10 |
| Operating Cash Flow | $-7,282 | $-3,007 | $-3,793 | $-2,650 | $-2,990 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -270 | -580 |
| Other Investing Activity | 0 | 1 | 231 | 2,530 | 2,750 |
| Investing Cash Flow | $N/A | $1 | $231 | $2,260 | $2,170 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 250 | N/A | N/A | N/A | N/A |
| Debt Issued | 1,501 | 3,158 | 3,824 | N/A | N/A |
| Other Financing Activity | 11,026 | -284 | -172 | 440 | 760 |
| Financing Cash Flow | $12,777 | $2,873 | $3,652 | $440 | $760 |
| Beginning Cash Position | 39 | 172 | 81 | 1,280 | 1,340 |
| End Cash Position | 5,534 | 39 | 172 | 1,330 | 1,280 |
| Net Cash Flow | $5,495 | $-133 | $91 | $40 | $-60 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,282 | -3,007 | -3,793 | -2,650 | -2,990 |
| Free Cash Flow | -7,282 | -3,007 | -3,793 | -2,650 | -2,990 |